The global urinary bag market is poised to surpass USD 1,899.3 million by 2023, surging at a remarkable CAGR of 4.4% through 2033 to reach USD 2,911.7 million.
The urinary bag market has experienced significant growth in recent years due to the increasing prevalence of urinary incontinence and urinary retention disorders. With growing environmental concerns, there is a rising emphasis on developing sustainable urinary bag solutions.
Furthermore, manufacturers are increasingly exploring eco-friendly materials, recycling initiatives, and waste reduction strategies to address these sustainability concerns.
What is the Impact of Consolidation Efforts on Urinary Bag Sales?
Acquisition by BD: On December 29, 2017, BD completed the acquisition of Bard, aiming to create a medical technology company that improves disease treatment and healthcare processes.
Hollister's Distribution Center: In 2018, Hollister Incorporated opened a new distribution center in the Netherlands, enhancing its distribution capabilities.
How Market Players are Gaining from Rising Cases of Chronic Ailments?
Urinary incontinence issues are very common in people over 40 years of age, according to a study released by the National Association for Continence in 2017. The condition leads to a low quality of life and an increased risk of morbidity. Various apps and marketing campaigns are being used by market players to raise awareness about urinary bags.
Attributes | Details |
---|---|
Urinary Bag Market Size (2023) | USD 1,899.3 million |
Urinary Bag Market Projected Size (2033) | USD 2,911.7 million |
Urinary Bag Market Value-based CAGR (2023 to 2033) | 4.4% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global urinary bag market expanded at a moderate CAGR of over 4.1% between 2018 and 2022. Continual growth in healthcare expenditure, particularly in developing economies, improves access to healthcare services and urinary management solutions. Increased investment in healthcare infrastructure is likely to drive the demand for urinary bags.
Ongoing advancements in urinary bag technology, including the incorporation of innovative features and materials, enhance product performance, patient comfort, and infection prevention. These advancements greatly contribute to increased adoption and market growth.
Leading companies are actively participating in partnerships, collaborations, and mergers and acquisitions to expand their product portfolio. Furthermore, the availability of advanced urinary bag products has also increased with the number of visits for cancer treatments in hospitals.
Such factors are expected to create opportunities for the expansion of the urinary bag market over the forecast period, which is projected to expand at a CAGR of 4.4% from 2023 to 2033.
The market in the United States of America accounts for more than 90% of North America market, where the market for urinary bags in North America was predicted to amass revenue of 34.5% in 2022.
The healthcare system of the United States of America is well-known for its infrastructure and spending and the same can be attributed to the country’s value share of 31.8% in 2022.
Applications in cancer care centers and hospitals are influenced by regulations and insurance policies, which in turn accelerates the growth of the market in the country.
Government and regulatory authorities in the United States of America are implementing several cost-containment plans to ease the burden on the healthcare sector.
The United States of America government is actively taking initiatives to encourage various research activities for the development and treatment of urinary diseases. Telefex completed two large-scale acquisitions: NeoTract, Inc. (NeoTract) and Vascular Solutions, Inc. (Vascular Solutions).
Germany held a share of 9.5% in 2022 and is expected to advance at a steady pace in the coming years.
Germany is one of the world’s leading production hubs for pharmaceutical and healthcare products. Manufacturers in the country have created a competitive environment by developing products and leveraging cutting-edge research for functionality improvements.
The manufacturers are constantly investing in operation expansions that enable companies to optimize research and development, resulting in a promising product pipeline. Moreover, the prioritization of areas with high patient needs and working toward the development of innovative products is likely to generate substantial returns.
The United Kingdom market is expected to secure a 4.4% CAGR from 2023 to 2033. The United Kingdom’s healthcare system is largely funded by the government. It is considered one of the most successful healthcare systems in the world.
According to FMI’s analysis, the United Kingdom is identified as the leading market among the countries of Europe. Furthermore, rising research efforts, increasing pipeline drugs, and the presence of several key players create a huge opportunity for urinary bag producers in the country.
The market in China is projected to expand at a CAGR of 4.4% during the forecast period. China is the second-large pharmaceutical market in the world. It is significantly growing based on two main factors such as large-scale capital investment and rapid productivity growth. These two factors have projected the country as an appealing destination for foreign investments and large domestic savings.
The country has been transforming from being a low economy to a market-oriented country since the 1970s. With the growth in medical tourism, the sales prospects of urinary bags are likely to remain positive for the foreseeable future.
India accounts for more than 50% of the South Asia urinary bag industry. In recent years, pharmaceutical companies in India have hugely invested in research operations. The demand for urinary bags is likely to grow, with significant impetus from the ongoing covid-19 pandemic.
As per FMI, the market for urinary bags in India is poised to expand at a rate of 6.9% from 2023 to 2033. Public-private partnerships have become a leading business in India due to factors such as the presence of government-funded pharmaceutical and medical institutions with advanced facilities for clinical trials.
Moreover, manufacturers in India are expanding their businesses by exporting their products to various other countries, which proves to be beneficial for India’s market.
Based on urinary bag products, drainage bags are leading the market and held a market share of over 52.24% in 2022.
Various surgical interventions, such as urological surgeries, abdominal surgeries, and pelvic surgeries, often require temporary or permanent urinary drainage. The increasing number of surgical procedures performed globally contributes to the demand for drainage bags.
There is a growing trend toward home healthcare and long-term care for individuals with chronic illnesses or disabilities. These settings often require urinary drainage bags for patients who prefer to receive care at home, further driving the demand for these products.
Based on capacity, 1000 ml capacity urine bags are preferred since it allows for easy movement of patients with sufficient quantity. This helps the patient to move freely without significant addition of weight. As a result, the demand for 1000 ml capacity urine bags held a 35.09% value share in 2022, according to FMI.
The larger capacity of 1000 ml capacity urine bags can help reduce the feeling of fullness and discomfort experienced by patients with high urine output. It allows for efficient urine collection, preventing overflow or leakage, and providing improved comfort throughout the day or night.
Disposable urinary bags accounted for more than 75.9% of the global market share in 2022. These products offer satisfaction to users with a low risk of infectious diseases.
Users also choose disposable urinary drainage bags owing to ease of use. In the case of reusable bags, careful cleaning and disinfection according to FDA guidelines are critical to prevent infection transfer from one patient to the next. Since the risk of infection transmission is low with disposable urinary drainage bags, healthcare professionals tend to prefer them over normal urinary bags, swaying the share of the sub-segment.
Adult urinary bags accounted for more than 92.1% of the global market share in 2022. Overactive bladders and urinary urgency are most common in people over 40 years of age, according to a study released by the National Association for Continence in 2017.
The adult segment is anticipated to grow significantly during the forecast period, reflecting notable growth than pediatric products.
Urinary bag consumption by hospitals amassed a revenue share of 40.2% in 2022 as hospitals are highly preferred for patient care for ulcerative colitis and inflammatory bowel disease (IBD), especially among geriatrics. These diseases are common in developed economies, with high penetration in urban areas.
The COVID-19 epidemic has increased hospital admission rates all over the world, which in turn has bolstered urinary bag requirements.
The urinary bag market is consolidated in nature, with the presence of leading players operating in this space. The focus is primarily on research & development activities mainly for urinary retention, urine incontinence, and urological or gynecological surgeries.
Market players are also engaged in the expansion of global and regional presence through acquisitions, expansions, product launches, and improvement of distribution channels.
Developments in the market
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Asia Pacific is projected to emerge as a lucrative market for urinary bags.
The growth potential of the urinary bag market is 4.4% through 2033.
The high cost of adoption is likely to limit market growth.
North America is likely to generate 15% revenue in 2023.
The market will generate revenue of USD 2,911.7 million in 2033.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. Large Bags 5.2. Leg Bags 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Usage 6.1. Reusable 6.2. Disposable 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Capacity 7.1. Upto 500 ml 7.2. 500-1000 ml 7.3. Above 1000 ml 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 8.1. Hospitals and Clinics 8.2. Others 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 9.1. North America 9.2. Latin America 9.3. Europe 9.4. Asia Pacific 9.5. MEA 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. Key Countries Market Analysis 16. Market Structure Analysis 17. Competition Analysis 17.1. Medline Industries, Inc. 17.2. Cardinal Health, Inc. 17.3. Hollister Incorporated 17.4. Teleflex Incorporated 17.5. Cook Medical 17.6. Moore Medical LLC 17.7. Mckesson Medical-Surgical Inc. 17.8. Arcus Medical LLC 17.9. Urocare 17.10. Covidien 17.11. Coloplast A/S 17.12. B. Braun 17.13. Romsons 17.14. Poly Medicure Limited 17.15. G.Surgiwear Ltd 17.16. Kiefel Medical 17.17. Jolfamar 17.18. UROMED 17.19. Wujiang Evergreen Ex/Im Co. Ltd 17.20. Leboo Healthcare Products Limited 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports